A review of clinical trials of cetuximab combined with radiotherapy for non-small cell lung cancer

Clinical prognostic factors in patients with locally advanced (stage III) nonsmall cell lung cancer treated with hyperfractionated radiation therapy with and without concurrent chemotherapy

(2011) Branislav Jeremić et al.   CANCER

Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancer

(2011) Samir Sejpal et al.   CANCER

Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity-modulated RT radiotherapy and cetuximab

(2011) Alexandra D. Jensen et al.   CANCER

Therapeutic implications of molecular imaging with PET in the combined modality treatment of lung cancer

(2011) Judith van Loon et al.   CANCER TREATMENT REVIEWS

EGF61 Polymorphism Predicts Complete Pathologic Response to Cetuximab-Based Chemoradiation Independent of KRAS Status in Locally Advanced Rectal Cancer Patients

(2011) S. Hu-Lieskovan et al.   CLINICAL CANCER RESEARCH

Prospective Study of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Concurrent With Individualized Radiotherapy for Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer

(2011) Jing Wang et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Randomized Phase II Study of Pemetrexed, Carboplatin, and Thoracic Radiation With or Without Cetuximab in Patients With Locally Advanced Unresectable Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B Trial 30407

(2011) Ramaswamy Govindan et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Study of Cetuximab in Combination With Chemoradiation in Patients With Stage IIIA/B Non–Small-Cell Lung Cancer: RTOG 0324

(2011) George R. Blumenschein et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Trial of Induction Gemcitabine and Carboplatin Followed by Conformal Thoracic Radiation to 74 Gy with Weekly Paclitaxel and Carboplatin in Unresectable Stage III Non-small Cell Lung Cancer

(2011) Gerold Bepler et al.   Journal of Thoracic Oncology

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

(2011) William D. Travis et al.   Journal of Thoracic Oncology

Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study

(2011) Kenneth J O'Byrne et al.   LANCET ONCOLOGY

Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer

(2011) Praveena Cheruvu et al.   Radiation Oncology

Cisplatin-based chemoradiation plus cetuximab in locally advanced head and neck cancer: a phase II clinical study

(2010) M. Merlano et al.   ANNALS OF ONCOLOGY

A phase II study of cetuximab and radiation in elderly and/or poor performance status patients with locally advanced non-small-cell lung cancer (N0422)

(2010) A. Jatoi et al.   ANNALS OF ONCOLOGY

Phase 2 trial of concurrent 5-fluorouracil, hydroxyurea, cetuximab, and hyperfractionated intensity-modulated radiation therapy for locally advanced head and neck cancer

(2010) Johnny Kao et al.   CANCER

Chemoradiation therapy in nonsmall cell lung cancer

(2010) Paul Baas et al.   CURRENT OPINION IN ONCOLOGY

Potential of Adaptive Radiotherapy to Escalate the Radiation Dose in Combined Radiochemotherapy for Locally Advanced Non–Small Cell Lung Cancer

(2010) Matthias Guckenberger et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Analysis of Potential Predictive Markers of Cetuximab Benefit in BMS099, a Phase III Study of Cetuximab and First-Line Taxane/Carboplatin in Advanced Non–Small-Cell Lung Cancer

(2010) Shirin Khambata-Ford et al.   JOURNAL OF CLINICAL ONCOLOGY

Induction Docetaxel, Cisplatin, and Cetuximab Followed by Concurrent Radiotherapy, Cisplatin, and Cetuximab and Maintenance Cetuximab in Patients With Locally Advanced Head and Neck Cancer

(2010) Athanassios Argiris et al.   JOURNAL OF CLINICAL ONCOLOGY

Primary Analysis of the Phase II Component of a Phase I/II Dose Intensification Study Using Three-Dimensional Conformal Radiation Therapy and Concurrent Chemotherapy for Patients With Inoperable Non–Small-Cell Lung Cancer: RTOG 0117

(2010) Jeffrey D. Bradley et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase III Trial Comparing Docetaxel and Cisplatin Combination Chemotherapy With Mitomycin, Vindesine, and Cisplatin Combination Chemotherapy With Concurrent Thoracic Radiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: OLCSG 0007

(2010) Yoshihiko Segawa et al.   JOURNAL OF CLINICAL ONCOLOGY

European Organisation for Research and Treatment of Cancer Recommendations for Planning and Delivery of High-Dose, High-Precision Radiotherapy for Lung Cancer

(2010) Dirk De Ruysscher et al.   JOURNAL OF CLINICAL ONCOLOGY

Chemoradiotherapy and Gefitinib in Stage III Non-small Cell Lung Cancer with Epidermal Growth Factor Receptor and KRAS Mutation Analysis: Cancer and Leukemia Group B (CALEB) 30106, a CALGB-Stratified Phase II Trial

(2010) Neal Ready et al.   Journal of Thoracic Oncology

Concurrent cetuximab and radiotherapy after docetaxel–cisplatin induction chemotherapy in stage III NSCLC: Satellite—A phase II study from the Swedish Lung Cancer Study Group

(2010) A. Hallqvist et al.   LUNG CANCER

Maintenance and Consolidation Therapy in Patients with Unresectable Stage III/IV Non-Small Cell Lung Cancer

(2010) N. Thatcher et al.   ONCOLOGIST

Combined Modality Therapy for Stage III Non–Small-Cell Lung Cancer

(2010) Cynthia S. Anderson et al.   SEMINARS IN RADIATION ONCOLOGY

Non-Small Cell Lung Cancer in Stages I–IIIB

(2010) Karl Wurstbauer et al.   STRAHLENTHERAPIE UND ONKOLOGIE

The Use of FDG-PET to Target Tumors by Radiotherapy

(2010) Guido Lammering et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Nonresected Non–Small-Cell Lung Cancer in Stages I Through IIIB: Accelerated, Twice-Daily, High-Dose Radiotherapy—A Prospective Phase I/II Trial With Long-Term Follow-Up

(2009) Karl Wurstbauer et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

(2009) James A Bonner et al.   LANCET ONCOLOGY

Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in non-small cell lung cancer

(2009) Erik P Sulman et al.   Radiation Oncology

The Effect of Radiation Dose and Chemotherapy on Overall Survival in 237 Patients With Stage III Non–Small-Cell Lung Cancer

(2008) Li Wang et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

A Phase II Study of Synchronous Three-Dimensional Conformal Boost to the Gross Tumor Volume for Patients With Unresectable Stage III Non–Small-Cell Lung Cancer: Results of Korean Radiation Oncology Group 0301 Study

(2008) Kwan Ho Cho et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Randomized Phase II Trial of Induction Chemotherapy Followed by Concurrent Chemotherapy and Dose-Escalated Thoracic Conformal Radiotherapy (74 Gy) in Stage III Non–Small-Cell Lung Cancer: CALGB 30105

(2008) Mark A. Socinski et al.   JOURNAL OF CLINICAL ONCOLOGY

A Brief Report on the Safety Study of Induction Chemotherapy Followed by Synchronous Radiotherapy and Cetuximab in Stage III Non-small Cell Lung Cancer (NSCLC): SCRATCH Study

(2008) Simon Hughes et al.   Journal of Thoracic Oncology

Oral Vinorelbine and Cisplatin as Induction Chemotherapy and Concomitant Chemo-Radiotherapy in Stage III Non-small Cell Lung Cancer: Final Results of an International Phase II Trial

(2008) Maciej Krzakowski et al.   Journal of Thoracic Oncology

The impact of functional imaging on radiation medicine

(2008) Nidhi Sharma et al.   Radiation Oncology